[go: up one dir, main page]

ZA931132B - Novel process. - Google Patents

Novel process.

Info

Publication number
ZA931132B
ZA931132B ZA931132A ZA931132A ZA931132B ZA 931132 B ZA931132 B ZA 931132B ZA 931132 A ZA931132 A ZA 931132A ZA 931132 A ZA931132 A ZA 931132A ZA 931132 B ZA931132 B ZA 931132B
Authority
ZA
South Africa
Prior art keywords
novel process
formula
compounds
chem
nitrosating
Prior art date
Application number
ZA931132A
Other languages
English (en)
Inventor
Mark Jason Hughes
John Kitteringham
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA931132B publication Critical patent/ZA931132B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
ZA931132A 1992-02-20 1993-02-18 Novel process. ZA931132B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929203688A GB9203688D0 (en) 1992-02-20 1992-02-20 Novel process

Publications (1)

Publication Number Publication Date
ZA931132B true ZA931132B (en) 1993-10-14

Family

ID=10710781

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931132A ZA931132B (en) 1992-02-20 1993-02-18 Novel process.

Country Status (19)

Country Link
US (2) US5545740A (es)
EP (2) EP0626961B1 (es)
JP (1) JP3288704B2 (es)
KR (1) KR100261530B1 (es)
AT (1) ATE194341T1 (es)
AU (1) AU669355B2 (es)
CA (1) CA2131019C (es)
DE (1) DE69328962T2 (es)
DK (1) DK0626961T3 (es)
ES (1) ES2147749T3 (es)
GB (1) GB9203688D0 (es)
GR (1) GR3034295T3 (es)
HK (1) HK1012366A1 (es)
MX (1) MX9300875A (es)
NZ (1) NZ246940A (es)
PT (1) PT626961E (es)
TW (1) TW224466B (es)
WO (1) WO1993017018A1 (es)
ZA (1) ZA931132B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9300875A (es) 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.
GB9409705D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
GB9421472D0 (en) * 1994-10-25 1994-12-07 Smithkline Beecham Plc Novel methods
GB9615628D0 (en) * 1996-07-25 1996-09-04 Smithkline Beecham Plc Formulation
JP2001520653A (ja) * 1997-04-11 2001-10-30 エリ リリー アンド カンパニー 精神分裂病の治療法
WO1998046227A1 (en) * 1997-04-11 1998-10-22 Eli Lilly And Company Composition for treating pain
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2651813A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1600969A (en) 1977-01-07 1981-10-21 Acf Chemiefarma Nv Heterocyclic compounds
US4937239A (en) * 1989-02-13 1990-06-26 Warner-Lambert Company Azabicycloalkane oxime & azabicycloalkene oxime muscarinic agents
SG48315A1 (en) * 1989-04-13 1998-04-17 Beecham Group Plc Novel compounds
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5418240A (en) 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
MX9300875A (es) 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.

Also Published As

Publication number Publication date
CA2131019C (en) 2002-12-24
EP0984008A3 (en) 2000-05-03
GB9203688D0 (en) 1992-04-08
KR950700292A (ko) 1995-01-16
EP0984008A2 (en) 2000-03-08
CA2131019A1 (en) 1993-08-21
AU3460793A (en) 1993-09-13
NZ246940A (en) 1996-06-25
DE69328962D1 (de) 2000-08-10
KR100261530B1 (ko) 2000-08-01
JPH07504180A (ja) 1995-05-11
DE69328962T2 (de) 2000-12-28
HK1012366A1 (en) 1999-07-30
ES2147749T3 (es) 2000-10-01
TW224466B (es) 1994-06-01
EP0626961B1 (en) 2000-07-05
EP0626961A1 (en) 1994-12-07
PT626961E (pt) 2000-10-31
JP3288704B2 (ja) 2002-06-04
ATE194341T1 (de) 2000-07-15
US6596869B2 (en) 2003-07-22
WO1993017018A1 (en) 1993-09-02
US20020143185A1 (en) 2002-10-03
DK0626961T3 (da) 2000-11-06
US5545740A (en) 1996-08-13
GR3034295T3 (en) 2000-12-29
MX9300875A (es) 1993-08-31
AU669355B2 (en) 1996-06-06

Similar Documents

Publication Publication Date Title
TW224466B (es)
HUT57043A (en) Process for producing pharmaceutical solutions comprising macrolide
HU906029D0 (en) Process for the preparation of pleuromuthylyne derivatives
TW223645B (es)
HU908122D0 (en) Process for producing nitrogen containing spirocycles
HU910847D0 (en) Process for producing chloro-triazole derivatives
FI931888A (fi) Kramploesande cykliska fruktopyranossulfiter -och sulfater
EP0742209A3 (en) Process for the preparation of an optically active quinoline demevalonolacton and process for the preparation of a salt of an optically active quinoline demevalolon
EP0320118A3 (en) Peptides with collagenase inhibiting activity
NO894349D0 (no) Tienopyridin-type mevalonolaktoner.
HU910748D0 (en) New substituted amine compounds and process for producing them
AU2202892A (en) Ammonium salt of methyl 4,4,4-trifluoro-3-oxo-butanethioate
EP0590681A3 (en) A process for the preparation of aminothiadiazolylacetyl halide derivatives
PT78636A (en) Process for the preparation esters of 2-bromo-4-methylimidazole-5-carboxylic acid
TW265342B (es)
SG43092A1 (en) Process for preparing 5-arylhydantoin
GB8707200D0 (en) Chemical process
CA2193310A1 (fr) Nouveau derive de 4-imidazolidinone, son procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0844236A4 (en) METHOD FOR PRODUCING CARBAMOYL METHYL URINE DERIVATIVES
ES8304546A1 (es) Un procedimiento de preparacion de zomepirac y sus analogos.
GB8721373D0 (en) Chemical process